{
  "summary": "<think>\nOkay, I need to summarize this document about Angus Russell in 3-5 sentences. Let me start by reading through the content carefully.\n\nThe document mentions that Angus Russell is a British businessman who was the CEO of Shire plc from 2008 to 2013. His early life includes being a chartered accountant and a fellow of the Association of Corporate Treasurers. His career path includes roles at ICI, Zeneca, AstraZeneca, and then Shire, where he started as CFO before becoming CEO. He was succeeded by Flemming Ørnskov from Bayer in 2013. His personal life notes that his wife is in Montreal.\n\nThe main topic is his professional career, especially his roles at Shire and previous companies. Key concepts are his positions, the timeline of his leadership, and his background. I should focus on his roles, the companies he worked for, and the transition of his CEO position. Also, mention his early qualifications. Need to keep it concise, avoiding personal details unless necessary. Let me structure the sentences to cover his career highlights, the companies, and the key events like his tenure and successor.\n</think>\n\nAngus C. Russell is a British businessman who served as CEO of Shire plc, a multinational biopharmaceutical company, from 2008 to 2013. Prior to this, he held roles such as CFO and executive vice president of global finance at Shire, following a 19-year career at companies like ICI, Zeneca, and AstraZeneca. Russell, a chartered accountant and fellow of the Association of Corporate Treasurers, succeeded Matthew Emmens as CEO and was later succeeded by Flemming Ørnskov of Bayer. His career highlights his expertise in corporate finance and leadership in the pharmaceutical industry.",
  "qa_pairs": [
    {
      "reasoning": "The passage states 'Angus C. [S2] Russell' in the chunk, where [S2] explicitly provides the full name 'Angus C. Russell'. This directly answers the question about his full name. Other citations mention his career or personal details but do not include his full name. The citation [S2] is the only one that addresses the question, making it the correct and supported reference.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What is Angus Russell's full name?",
      "answer": "<statement>Angus C. Russell.<cite>[S2]</cite></statement>"
    },
    {
      "reasoning": "The question asks for Angus Russell's birth date. The passage in [S2] explicitly states 'Angus C. Russell (born 2 January 1956)', which directly provides the birth date. The citation [S2] is the only source in the passage that includes this information, making it the correct and necessary reference to answer the question.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "When was Angus Russell born?",
      "answer": "<statement>2 January 1956.<cite>[S2]</cite></statement>"
    },
    {
      "reasoning": "The passage states that Angus C. Russell is a British businessman, which directly identifies his nationality. The citation [S2] refers to the sentence mentioning his nationality, confirming the answer.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What is Angus Russell's nationality?",
      "answer": "<statement>British.<cite>[S2]</cite></statement>"
    },
    {
      "reasoning": "The answer states that Angus Russell was the CEO of Shire plc from 2008 to 2013. The cited sentence [S3] explicitly mentions 'He was the chief executive (CEO) of Shire plc... from 2008 to 2013,' directly confirming the company and the time period. This matches the question's requirements, making [S3] the valid supporting citation.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "Which company was Angus Russell the CEO of from 2008 to 2013?",
      "answer": "<statement>Shire plc.<cite>[S3]</cite></statement>"
    },
    {
      "reasoning": "The answer states that Shire plc is a 'multinational speciality biopharmaceutical manufacturing company.' This directly matches the description in [S3], which explicitly identifies Shire plc as such. The citation is valid because [S3] provides the specific information about the company's primary business. Other sentences in the passage focus on Angus Russell's roles or personal details, which are unrelated to the question.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What was the primary business of Shire plc?",
      "answer": "<statement>A multinational speciality biopharmaceutical manufacturing company.<cite>[S3]</cite></statement>"
    },
    {
      "reasoning": "The passage states in [S5] that Angus Russell was appointed as CEO of Shire plc on 18 June 2008, 'taking over from Matthew Emmens, who became the non-executive chairman.' This directly identifies Matthew Emmens as Russell's predecessor as CEO. The citation [S5] explicitly supports the answer by confirming Emmens' role as the outgoing CEO before Russell's appointment.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "Who was Angus Russell's predecessor as CEO of Shire plc?",
      "answer": "<statement>Matthew Emmens.<cite>[S5]</cite></statement>"
    },
    {
      "reasoning": "The passage states in [S7] that Angus Russell was the chief financial officer (CFO) of Shire plc from 1999 to 2008. This directly answers the question about his role at Shire plc prior to becoming CEO. The citation [S7] explicitly confirms the CFO position and the timeframe, which aligns with the answer provided.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What role did Angus Russell hold at Shire plc before becoming CEO?",
      "answer": "<statement>Chief Financial Officer (CFO) from 1999 to 2008.<cite>[S7]</cite></statement>"
    },
    {
      "reasoning": "The answer identifies Angus Russell's roles at Shire plc besides CFO as 'principal accounting officer and executive vice president of global finance.' This is directly supported by [S6], which states that Russell was the chief financial officer (CFO) of Shire from 1999 to 2008 and also held the roles of 'principal accounting officer and executive vice president of global finance.' The citation explicitly lists these additional roles alongside his CFO position, confirming they were held concurrently. Thus, the answer accurately reflects the information in [S6].",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What were Angus Russell's roles at Shire plc besides CFO?",
      "answer": "<statement>Principal accounting officer and executive vice president of global finance.<cite>[S6]</cite></statement>"
    },
    {
      "reasoning": "The answer cites sentence [S8], which explicitly states that Angus Russell worked at ICI, Zeneca, and AstraZeneca prior to joining Shire plc. This directly addresses the question about his previous employers, making [S8] the relevant and supporting citation.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "Where did Angus Russell work before joining Shire plc?",
      "answer": "<statement>ICI, Zeneca, and AstraZeneca.<cite>[S8]</cite></statement>"
    },
    {
      "reasoning": "The passage states in [S8] that Angus Russell was 'vice president of corporate finance at AstraZeneca plc' prior to joining Shire. This directly answers the question about his role at AstraZeneca. The citation [S8] is used because it explicitly mentions his position at the company.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What was Angus Russell's role at AstraZeneca plc?",
      "answer": "<statement>Vice president of corporate finance.<cite>[S8]</cite></statement>"
    },
    {
      "reasoning": "The passage states in [S9] that 'On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO.' This directly answers the question by identifying Flemming Ørnskov of Bayer as the individual who succeeded Angus Russell as CEO of Shire plc in 2013. The citation [S9] explicitly confirms this transition, making it the supporting evidence for the answer.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "Who succeeded Angus Russell as CEO of Shire plc in 2013?",
      "answer": "<statement>Flemming Ørnskov of Bayer.<cite>[S9]</cite></statement>"
    },
    {
      "reasoning": "The answer states that Angus Russell was appointed as CEO of Shire plc on 18 June 2008. This date is explicitly mentioned in [S5], which directly supports the answer. The citation [S5] is the primary source for this information in the passage.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "When was Angus Russell appointed as CEO of Shire plc?",
      "answer": "<statement>18 June 2008.<cite>[S5]</cite></statement>"
    },
    {
      "reasoning": "The passage states that Angus Russell took over as CEO from Matthew Emmens, who 'became the non-executive chairman' (S6). This directly answers the question by specifying Emmens' role after Russell's appointment. The citation [S6] explicitly links Emmens' transition to the non-executive chairman position following Russell's assumption of the CEO role.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What role did Matthew Emmens take after Angus Russell became CEO?",
      "answer": "<statement>Non-executive chairman.<cite>[S6]</cite></statement>"
    },
    {
      "reasoning": "The passage states under the 'Personal life' section: 'His wife lives in Montreal, Quebec, Canada.' This directly answers the question about Angus Russell's wife's residence. The citation [S9] corresponds to this specific sentence, which explicitly provides the location of his wife's residence.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "Where does Angus Russell's wife live?",
      "answer": "<statement>Montreal, Quebec, Canada.<cite>[S9]</cite></statement>"
    },
    {
      "reasoning": "The answer states that Angus Russell was the Chief Executive Officer (CEO) of Shire plc in 2008. [S3] explicitly confirms he served as CEO from 2008 to 2013, directly supporting the answer. [S6] provides additional context by specifying he was appointed CEO on 18 June 2008, aligning with the 2008 timeframe mentioned in the question. Both citations corroborate the role of CEO during the requested period.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What was Angus Russell's position at Shire plc in 2008?",
      "answer": "<statement>Chief executive officer (CEO).<cite>[S3][S6]</cite></statement>"
    },
    {
      "reasoning": "The passage states in [S7] that Angus Russell worked at ICI, Zeneca, and AstraZeneca for 19 years combined. This directly answers the question by providing the total duration of his employment at these three companies. The citation [S7] explicitly mentions the 19-year span, making it the supporting evidence for the answer.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "How long did Angus Russell work at ICI, Zeneca, and AstraZeneca combined?",
      "answer": "<statement>19 years.<cite>[S7]</cite></statement>"
    },
    {
      "reasoning": "The passage states in [S9] that 'On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO.' This implies that Angus Russell's departure as CEO occurred on the same date, as his successor assumed the role on 30 April 2013. While the passage does not explicitly mention Russell's departure date, the citation directly ties the transition to this date, making it the logical answer.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What was the date of Angus Russell's departure as CEO of Shire plc?",
      "answer": "<statement>30 April 2013.<cite>[S9]</cite></statement>"
    },
    {
      "reasoning": "The passage states in [S7] that Angus Russell was the chief financial officer of Shire from 1999 to 2008. Since the question asks for his title before 2008, and [S7] explicitly confirms he held the role of Chief Financial Officer (CFO) during that period, the citation directly supports the answer. The transition to CEO occurred in 2008, making [S7] the relevant evidence for his pre-2008 role.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What was the title of Angus Russell's role at Shire plc before 2008?",
      "answer": "<statement>Chief Financial Officer (CFO).<cite>[S7]</cite></statement>"
    },
    {
      "reasoning": "The answer is derived from sentence [S7], which explicitly states that Angus Russell worked at ICI, Zeneca, and AstraZeneca prior to joining Shire. Sentence [S8] provides additional context about his role at AstraZeneca but is not directly necessary to answer the question. The key information about the companies he worked at before Shire is explicitly cited in [S7].",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What was the name of the company that employed Angus Russell prior to Shire?",
      "answer": "<statement>ICI, Zeneca, and AstraZeneca.<cite>[S7][S8]</cite></statement>"
    },
    {
      "reasoning": "The passage in [S3] explicitly states that Angus Russell was the 'chief executive (CEO)' of Shire plc from 2008 to 2013. This directly answers the question about his full title at Shire plc as of 2008. The citation supports the answer because it identifies his role as CEO, which aligns with the provided statement.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What is the full title of Angus Russell's role at Shire plc as of 2008?",
      "answer": "<statement>Chief executive officer (CEO).<cite>[S3]</cite></statement>"
    },
    {
      "reasoning": "The answer states that Angus Russell's primary responsibility as Shire's CFO was being the 'principal accounting officer and executive vice president of global finance.' This is directly supported by [S7], which explicitly mentions these roles during his tenure as CFO (1999–2008. The sentence links his CFO position to these specific responsibilities, making it the relevant citation.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What was the primary responsibility of Angus Russell as Shire's CFO?",
      "answer": "<statement>Principal accounting officer and executive vice president of global finance.<cite>[S7]</cite></statement>"
    },
    {
      "reasoning": "The passage states in [S5] that Angus Russell is a fellow of the Association of Corporate Treasurers. This directly answers the question about the organization he is a fellow of. The citation [S5] is the only relevant sentence here, as it explicitly mentions the organization's name.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What is the name of the organization Angus Russell is a fellow of?",
      "answer": "<statement>The Association of Corporate Treasurers.<cite>[S5]</cite></statement>"
    },
    {
      "reasoning": "The passage states in [S9] that 'Flemming Ørnskov of Bayer took over as CEO.' This directly indicates that Flemming Ørnskov represented Bayer when he became Shire's CEO in 2013. The citation [S9] explicitly supports the answer by linking Ørnskov to Bayer at the time of his appointment.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "Which company did Flemming Ørnskov represent when he became Shire's CEO in 2013?",
      "answer": "<statement>Bayer.<cite>[S9]</cite></statement>"
    },
    {
      "reasoning": "The answer states that Angus Russell's tenure as Shire's CEO was from 2008 to 2013. Citation [S3] explicitly mentions this timeframe ('He was the chief executive (CEO) of Shire plc... from 2008 to 2013'), directly supporting the answer. Additional context from [S6] (appointment in 2008) and [S9] (transition in 2013) corroborates the dates, but [S3] is the primary source specifying the duration.",
      "chunk": "[S1] Angus Russell\n\n\n# Angus Russell\n\n\n\n**Angus C. [S2] Russell** (born 2 January 1956) is a British businessman. [S3] He was the chief executive (CEO) of Shire plc, a multinational speciality biopharmaceutical manufacturing company from 2008 to 2013. [S4] ## Early life\n\nRussell qualified as a chartered accountant with Coopers & Lybrand and is a fellow of the Association of Corporate Treasurers. [S5] ## Career\n\nRussell was appointed as the chief executive officer of Shire plc on 18 June 2008, taking over from Matthew Emmens, who became the non-executive chairman. [S6] Russell was the chief financial officer of Shire from 1999 to 2008, and its principal accounting officer and executive vice president of global finance. [S7] Prior to joining Shire, Russell worked at ICI, Zeneca and AstraZeneca for 19 years, most recently as vice president of corporate finance at AstraZeneca plc. [S8] On 30 April 2013, Flemming Ørnskov of Bayer took over as CEO. [S9] ## Personal life\n\nHis wife lives in Montreal, Quebec, Canada.",
      "question": "What is the duration of Angus Russell's tenure as Shire's CEO?",
      "answer": "<statement>From 2008 to 2013.<cite>[S3]</cite></statement>"
    }
  ]
}